128 related articles for article (PubMed ID: 22204653)
21. Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer.
Xia HH; Yang Y; Chu KM; Gu Q; Zhang YY; He H; Wong WM; Leung SY; Yuen ST; Yuen MF; Chan AO; Wong BC
Cancer; 2009 Dec; 115(23):5441-9. PubMed ID: 19685530
[TBL] [Abstract][Full Text] [Related]
22. Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer.
Huang LJ; Chen SX; Huang Y; Luo WJ; Jiang HH; Hu QH; Zhang PF; Yi H
Lung Cancer; 2006 Oct; 54(1):87-94. PubMed ID: 16876904
[TBL] [Abstract][Full Text] [Related]
23. Pathway-based biomarker search by high-throughput proteomics profiling of secretomes.
Lawlor K; Nazarian A; Lacomis L; Tempst P; Villanueva J
J Proteome Res; 2009 Mar; 8(3):1489-503. PubMed ID: 19199430
[TBL] [Abstract][Full Text] [Related]
24. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
25. Angiopoietin-like protein 2 is a potential biomarker for gastric cancer.
Yoshinaga T; Shigemitsu T; Nishimata H; Takei T; Yoshida M
Mol Med Rep; 2015 Apr; 11(4):2653-8. PubMed ID: 25484242
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of gastric cancer by serum proteomic fingerprinting.
Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK
Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748
[TBL] [Abstract][Full Text] [Related]
27. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
[TBL] [Abstract][Full Text] [Related]
28. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
29. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
Planque C; Li L; Zheng Y; Soosaipillai A; Reckamp K; Chia D; Diamandis EP; Goodglick L
Clin Cancer Res; 2008 Mar; 14(5):1355-62. PubMed ID: 18316555
[TBL] [Abstract][Full Text] [Related]
30. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum.
Piersma SR; Fiedler U; Span S; Lingnau A; Pham TV; Hoffmann S; Kubbutat MH; Jiménez CR
J Proteome Res; 2010 Apr; 9(4):1913-22. PubMed ID: 20085282
[TBL] [Abstract][Full Text] [Related]
31. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
[TBL] [Abstract][Full Text] [Related]
32. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
33. Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways.
Caccia D; Zanetti Domingues L; Miccichè F; De Bortoli M; Carniti C; Mondellini P; Bongarzone I
J Proteome Res; 2011 Sep; 10(9):4196-207. PubMed ID: 21751813
[TBL] [Abstract][Full Text] [Related]
34. Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS.
Mbeunkui F; Fodstad O; Pannell LK
J Proteome Res; 2006 Apr; 5(4):899-906. PubMed ID: 16602697
[TBL] [Abstract][Full Text] [Related]
35. Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility.
Weng LP; Wu CC; Hsu BL; Chi LM; Liang Y; Tseng CP; Hsieh LL; Yu JS
J Proteome Res; 2008 Sep; 7(9):3765-75. PubMed ID: 18646789
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.
Bai J; Zhou Y; Chen G; Zeng J; Ding J; Tan Y; Zhou J; Li G
Hum Pathol; 2011 Mar; 42(3):375-83. PubMed ID: 21190721
[TBL] [Abstract][Full Text] [Related]
37. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
He Y; Wu X; Liu X; Yan G; Xu C
J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
[TBL] [Abstract][Full Text] [Related]
38. Serum HDL-C as a potential biomarker for nodal stages in gastric cancer.
Guo E; Chen L; Xie Q; Chen J; Tang Z; Wu Y
Ann Surg Oncol; 2007 Sep; 14(9):2528-34. PubMed ID: 17597347
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Chen C; Chen LQ; Chen LD; Yang GL; Li Y
Hepatogastroenterology; 2008; 55(84):991-7. PubMed ID: 18705314
[TBL] [Abstract][Full Text] [Related]
40. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
